Wei‐Heng Xu

801 total citations
31 papers, 630 citations indexed

About

Wei‐Heng Xu is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Wei‐Heng Xu has authored 31 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Wei‐Heng Xu's work include Bioactive natural compounds (5 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Wei‐Heng Xu is often cited by papers focused on Bioactive natural compounds (5 papers), Liver physiology and pathology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Wei‐Heng Xu collaborates with scholars based in China, United States and India. Wei‐Heng Xu's co-authors include Junping Zhang, Cheng Guo, Zhenlin Hu, Lei Qiu, Xing Deng, Honggang Hu, Jie Li, Jing Wang, Xingxia Li and ZhongXiang Zhang and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Wei‐Heng Xu

29 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei‐Heng Xu China	16	302	105	101	83	83	31	630
Huey-Lan Huang Taiwan	14	349 1.2×	105 1.0×	153 1.5×	65 0.8×	56 0.7×	20	678
Chenxi Zhang China	11	197 0.7×	36 0.3×	79 0.8×	57 0.7×	53 0.6×	19	429
Fanying Meng China	18	333 1.1×	58 0.6×	80 0.8×	30 0.4×	45 0.5×	57	841
Chien‐Heng Shen Taiwan	19	342 1.1×	217 2.1×	213 2.1×	111 1.3×	207 2.5×	42	870
Xuanfu Xu China	14	470 1.6×	58 0.6×	159 1.6×	38 0.5×	63 0.8×	25	820
Dujuan Xu China	16	354 1.2×	71 0.7×	63 0.6×	128 1.5×	36 0.4×	33	661
Ming Yue Li China	17	480 1.6×	112 1.1×	57 0.6×	91 1.1×	19 0.2×	30	884
Weiya Cao China	13	355 1.2×	39 0.4×	215 2.1×	30 0.4×	42 0.5×	27	696
Ji-Hua Dong China	20	403 1.3×	62 0.6×	119 1.2×	280 3.4×	53 0.6×	39	1.1k

Countries citing papers authored by Wei‐Heng Xu

Since Specialization

Citations

This map shows the geographic impact of Wei‐Heng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Heng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Heng Xu more than expected).

Fields of papers citing papers by Wei‐Heng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Heng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Heng Xu. The network helps show where Wei‐Heng Xu may publish in the future.

Co-authorship network of co-authors of Wei‐Heng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Heng Xu. A scholar is included among the top collaborators of Wei‐Heng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Heng Xu. Wei‐Heng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Linlin, et al.. (2024). Anti-sepsis effects of Dahuang Mudan decoction and its disassembled prescriptions. Journal of Ethnopharmacology. 340. 119248–119248. 1 indexed citations

Wang, Xinrong, et al.. (2024). Discovery of petroselinic acid with in vitro and in vivo antifungal activity by targeting fructose-1,6-bisphosphate aldolase. Phytomedicine. 133. 155948–155948. 4 indexed citations

Zhang, Wannian, et al.. (2024). Pharmacokinetic, Tissue Distribution, Metabolite, and Toxicity Evaluation of the Matrine Derivative, (6aS, 10S, 11aR, 11bR, 11cS)-10-Methylaminododecahydro-3a, 7a-Diaza-benzo (de) Anthracene-8-thione. Molecules. 29(2). 297–297.

Wang, Chuanhao, Zhuo Qu, Wannian Zhang, et al.. (2024). Discovery of Sophoridine α-Aryl Propionamide Derivative ZM600 as a Novel Antihepatic Fibrosis Agent. Journal of Medicinal Chemistry. 67(13). 11389–11400. 2 indexed citations

Zhang, Jingxiang, et al.. (2024). ANXA3 as a novel biomarker for sepsis diagnosis: Evidence from integrative WGCNA analysis. Heliyon. 10(19). e38608–e38608. 1 indexed citations

Lv, Quanzhen, et al.. (2023). Protective Effect of a Novel RIPK1 Inhibitor, Compound 4–155, in Systemic Inflammatory Response Syndrome and Sepsis. Inflammation. 46(5). 1796–1809. 3 indexed citations

Chen, Yaping, Li Chen, Xiaoqin Zhang, et al.. (2022). The matrine derivate MASM inhibits astrocyte reactivity and alleviates experimental autoimmune encephalomyelitis in mice. International Immunopharmacology. 108. 108771–108771.

Xu, Wei‐Heng, Liming Fan, Yuqin Zhang, et al.. (2022). Polydatin alleviates DSS‐ and TNBS‐induced colitis by suppressing Th17 cell differentiation via directly inhibiting STAT3. Phytotherapy Research. 36(9). 3662–3671. 13 indexed citations

Fan, Liming, Yuqin Zhang, Yaping Chen, et al.. (2022). Cryptotanshinone ameliorates dextran sulfate sodium-induced murine acute and chronic ulcerative colitis via suppressing STAT3 activation and Th17 cell differentiation. International Immunopharmacology. 108. 108894–108894. 10 indexed citations

10.

Li, Tingting, Xiaowei Su, Linlin Chen, et al.. (2022). Roxarsone inhibits hepatic stellate cell activation and ameliorates liver fibrosis by blocking TGF-β1/Smad signaling pathway. International Immunopharmacology. 114. 109527–109527. 5 indexed citations

11.

Bai, Bingke, Qianbo Chen, Rui Jing, et al.. (2021). Molecular Basis of Prostate Cancer and Natural Products as Potential Chemotherapeutic and Chemopreventive Agents. Frontiers in Pharmacology. 12. 738235–738235. 22 indexed citations

12.

Lv, Diya, Jin Xu, Dongyao Wang, et al.. (2021). A strategy of screening and binding analysis of bioactive components from traditional Chinese medicine based on surface plasmon resonance biosensor. Journal of Pharmaceutical Analysis. 12(3). 500–508. 36 indexed citations

13.

An, Li, Junjie Wang, Xin Zhao, et al.. (2021). Two Reference-Quality Sea Snake Genomes Reveal Their Divergent Evolution of Adaptive Traits and Venom Systems. Molecular Biology and Evolution. 38(11). 4867–4883. 26 indexed citations

14.

Xu, Wei‐Heng, Jing Xu, Fangyuan Xie, et al.. (2019). The Matrine Derivate MASM Inhibits Recruitment of Gr1<sup>hi</sup> Monocyte and Alleviates Liver Injury. Pharmacology. 104(5-6). 235–243. 2 indexed citations

15.

Jing, Rui, et al.. (2019). Therapeutic effects of the total lignans from Vitex negundo seeds on collagen-induced arthritis in rats. Phytomedicine. 58. 152825–152825. 46 indexed citations

16.

Li, Yinghua, Yan Cao, Jing Xu, et al.. (2016). Esculentoside A suppresses lipopolysaccharide-induced pro-inflammatory molecule production partially by casein kinase 2. Journal of Ethnopharmacology. 198. 15–23. 18 indexed citations

17.

Liu, Ying, Qi Yang, Chenxu Ni, et al.. (2016). A novel matrine derivate inhibits differentiated human hepatoma cells and hepatic cancer stem-like cells by suppressing PI3K/AKT signaling pathways. Acta Pharmacologica Sinica. 38(1). 120–132. 38 indexed citations

18.

Wang, Keqi, Wei‐Heng Xu, Yinghua Li, et al.. (2016). The Matrine Derivate MASM Prolongs Survival, Attenuates Inflammation, and Reduces Organ Injury in Murine Established Lethal Sepsis. The Journal of Infectious Diseases. 214(11). 1762–1772. 19 indexed citations

19.

Xu, Wei‐Heng, Honggang Hu, Yuan Tian, et al.. (2014). Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosis. Hepatology. 60(2). 648–660. 48 indexed citations

20.

Li, Jie, Xingxia Li, Wei‐Heng Xu, et al.. (2014). Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways. Liver International. 35(4). 1222–1233. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact